Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 41, Issue 1, 2010, Pages 114-126

  Chotivitayatarakorn, Peeranath ^a   Chotivitayatarakorn, Pairoj ^b   Poovorawan, Yong ^c  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Department of Pediatrics   (Thailand)

^c NONE

Author keywords

Cost effectiveness; EPI; Rotavirus vaccine; Thailand

Indexed keywords

EID: 76949096728     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Adam T, Evans DB, Murray CJL. Econometric estimation of country-specific hospital costs. Cost Eff Resour Alloc 2003;1:3.
2. Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand. Annual epidemiology surveillance report 2006. Nonthaburi: Ministry of Public Health, 2006. (Cited 2009 Apr. 1). Available from: UR: http://203.157.15-4/(in Thai).
3. Carvalho-Costa FA, Ara jo IT, Santos de Assis RM, et al. Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil. Emerg Infect Dis 2009;15:95-7.
4. Committee on Infectious Diseases. Prevention of rotavirus disease: updated guideline for use of rotavirus vaccine. Pediatrics 2009. (Epub ahead of print).
5. Constenla DO, Linhares AC, Rheingans RD, Antil LR, Waldman EA, da Silva LJ. Economic impact of a rotavirus vaccine in Brazil. J Health Popul Nutr 2008;26:388-96.
6. Cortese MM, Parasha UD, Center for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Recomm Rep 2009;58:1-25.
7. Fischer TK, Anh DD, Antil L, et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005;192:1720-6.
8. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006;368:323-32.
9. Guilbert JJ. The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon) 2003;16:230.
10. Isakbaeva ET, Musabaev E, Antil L, et al. Rotavirus in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine 2007;25:373-80.
11. Jiraphongsa C, Bresee JS, Pongsuwanna Y, et al. Epidemiology and burden of rotavirus diarrhea in Thailand: results of sentinel surveillance. J Infect Dis 2005;192:S87-93.
12. Kim SY, Goldie SJ, Salomon JA. Cost-effectiveness of rotavirus vaccination in Vietnam. BMC Public Health 2009;9:29-40.
13. Linhares AC, Velázquez FR, Pérez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomized, double-blind, placebo-controlled phase III study. Lancet 2008;371:1181-9.
14. National Statistical Office of Thailand. Wages and salary, Thailand. Bangkok:National Statistical Office, 2008. (Cited 2009 Apr. 2). Available from: URL: http://service.nso. go.th/nso/nsopublish/indicator/indEco 51.pdf (in Thai). Nelson EA, Bresee JS, Parashar UD, Widdowson MA, Glass RI. Asian Rotavirus Surveillance Network. Rotavirus epidemiology: The Asian Rotavirus Surveillance Network. Vaccine 2008;26:3192-6.
15. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-72.
16. Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R. Projected costeffectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005;192:S133-45.
17. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Eng J Med 2006;354:11-22.
18. Salinas B, Pârez SI, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 2005;24:807-16.
19. Shepard DS, Walsh JA, Kleinau E, Stansfield S, Bhalotra S. Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach. Vaccine 1995;13:707-14.
20. Simmerman JM, Lertiendumrong J, Dowell SF, et al. The cost of influenza in Thailand. Vaccine 2006;24:4417-26.
21. Sungkapalee T, Puntukosit P, Eunsuwan O, Theamboonlers A, Chongsrisawat V, Poovorawan Y. Incidence and clinical manifestations of rotavirus infection among children with acute diarrhea admitted at Buri Ram Hospital, Thailand. Southeast Asian J Trop Med Public Health 2006;37:1125-31.
22. Thailand Department of Disease Control. Bureau of General Communicable Diseases. Vaccine coverage. Nonthaburi: Thailand Department of Diseases Control, 2008. (Cited 2009 Oct. 13). Available from: URL: http://thaigcd.ddc.moph.go.th/
23. The World Bank. World Development Report 1993: Investing in Health. 2006. (Cited 2009 Apr. 2). Available from: URL: http://www-wds.worldbank.org/ external/-default/WDSContentServer/WDSP/IB/1993/06/01/000009265 3970716142319/Rendered/PDF/multi0page.pdf
24. Theamboonlers A, Bhattarakosol P, Chongsrisawat V, Sungkapalee T, Wutthirattanakowit N, Poovorawan Y. Molecular characterization of group A human rotaviruses in Bangkok and Buriram, Thailand during 2004-2006 reveals the predominance of G1P[8], G9P[8] and a rare G3P[19] strain. Virus Genes 2008;36:289-98.
25. Theamboonlers A, Veravigrom M, Yambangyang O, Trairatvorakul P, Chongsrisawat V, Poovorawan Y. The incidence of rotavirus isolates of G genotype in Thailand in 2002-2004. Acta Virol 2005;49:111-5.
26. Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007;119:684-97.
27. World Health Organization (WHO). Choosing interventions that are cost effective: results of cost effectiveness analysis (WHO-CHOICE). Estimates of unit costs for patient services for Thailand. Geneva:WHO, 2008. (Cited 2009 Apr. 1). Available from: URL: http://www.who.int/choice/country/tha/cost/en/index. html
28. World Health Organization (WHO). External review of burden of disease attributable to Rotavirus. 30 November to 1 December 2005. Geneva: WHO, 2005. (Cited 2009 Apr. 1). Available from: URL: http://www.who.int/immunization- monitoring/burden/Rota-virus-Q5-mortality-estimates-external-review-report-2006- may.pdf
29. World Health Organization (WHO). Mortality country fact sheet 2006. Geneva:WHO, 2008. (Cited 2009 Apr. 2). Available from: URL: http://www.who.int/ whosis/mort/profiles/mort-searo-tha-thailand.pdf
30. World Health Organization (WHO). WHO-UNICEF estimates of immunization coverage: Thailand. Geneva:WHO, 2008. (Cite 2009 Apr. 1). Available from: URL: http://www.who.int/vaccines/globalsummary/immunization/timeseries/tswucoverage bycountry.cfm?country=THA
31. Wu CL, Yang YC, Huang LM, Chen KT. Costeffectiveness of childhood rotavirus vaccination in Taiwan. Vaccine 2009;27:1492-9.